A Multifactorial Azole Response in Clinically Relevant Fusarium Species Complexes
Mycoses · 2026
DOI: 10.1111/myc.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2026. Verfasst von Patrícia Helena Grizante Barião und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Analyses, Toxicology, and Food Science, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao…. Hauptthemen laut MEDLINE: Fusarium, Antifungal Agents, Azoles, Drug Resistance, Fungal. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Universidad de La Frontera.
Abstract (Originalsprache)
Background
Fusarium spp. are clinically relevant filamentous fungi with intrinsically low susceptibility to multiple antifungal agents, particularly azoles, and are included in the World Health Organization fungal priority pathogens list.
Objectives
To investigate azole resistance‐related mechanisms in clinical isolates belonging to the Fusarium solani species complex (FSSC), Fusarium oxysporum species complex (FOSC) and Fusarium fujikuroi species complex (FFSC) recovered in São Paulo, Brazil.
Methods
Twenty‐six clinical isolates were identified by sequencing of the ITS region, TEF1 and RPB2 . Antifungal susceptibility testing, CYP51A amplification and sequencing and expression analysis of CYP51A and ABC1 under voriconazole exposure were performed.
Results
Antifungal susceptibility testing showed broadly elevated azole MICs, with the FSSC displaying the least favourable profile. Comparative CYP51A analysis revealed distinct amino acid signatures among the three species complexes, including residues at positions equivalent to canonical azole resistance hotspots in Aspergillus fumigatus . However, no simple relationship was observed between CYP51A amino acid profiles and azole MIC values. In contrast, voriconazole exposure induced marked CYP51A upregulation in all tested isolates, with substantially higher expression in the higher‐MIC FSSC isolate. ABC1 was also upregulated in FSSC isolates, although at markedly lower levels than CYP51A .
Conclusions
These findings support a multifactorial model of azole response in Fusarium species complex strains, involving conserved CYP51A sequence features, strong target‐gene induction under antifungal stress, and a lower but detectable contribution of efflux‐associated mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Analyses, Toxicology, and Food Science, School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
- Scientific and Technological Bioresource Nucleus (BIORENUFRO), Universidad de La Frontera, Temuco, Chile.
- Postgraduate Program in Biotechnology, Federal University of Technology-Paraná, Ponta Grossa, PR, Brazil.
ORCID-Profile: Marcia Regina von Zeska Kress
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Universidad de La Frontera
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Grizante Barião, P. H., Tonani, L., Alves, A. R., de Almeida, O. G. G., Santos, C., & von Zeska Kress, M. R. (2026). A Multifactorial Azole Response in Clinically Relevant Fusarium Species Complexes. Mycoses. https://doi.org/10.1111/myc.70220
Vancouver
Grizante Barião PH, Tonani L, Alves AR, de Almeida OGG, Santos C, von Zeska Kress MR. A Multifactorial Azole Response in Clinically Relevant Fusarium Species Complexes. Mycoses. 2026. doi:10.1111/myc.70220
BibTeX
@article{GrizanteBario2026,
author = {Grizante Barião, Patrícia Helena and Tonani, Ludmilla and Alves, Adriana Rodrigues and de Almeida, Otávio Guilherme Gonçalves and Santos, Cledir and von Zeska Kress, Marcia Regina},
title = {A Multifactorial Azole Response in Clinically Relevant Fusarium Species Complexes},
journal = {Mycoses},
year = {2026},
doi = {10.1111/myc.70220}
}
EUVIMED